[1] All of these pathophysiologic features are largely represented in asthma, and therefore, anticholinergic drugs have been considered ... Forced vital capacity; ICS: Inhaled corticosteroids ...

Current controller drugs for asthma include ICS, LABA, LTRA, omalizumab and theophylline. Current rescue drugs for asthma include short-acting β 2 agonists (SABA), short-acting muscarinic ...

An afternoon dose also yielded significantly better overnight (10 p.m. to 4 a.m.) suppression in blood eosinophil counts as a ...

and LABAs with LAMAs and ICS. Using these drugs in combination can often improve long-term control. Within each class of ...

Background and goal: Inhaled corticosteroids (ICS) are commonly prescribed for chronic obstructive pulmonary disease (COPD), but not recommended as first-line treatment unless patients have asthma ...

LABA as monotherapy (without ICS) for asthma can increase risk of asthma ... should be instructed to discontinue the regular use of these drugs. Avoid Excessive Use of Trelegy Ellipta and Avoid ...

mometasone furoate given in a once-daily dose – showed that the two-drug combination performed better than the ICS alone in patients with poorly-controlled asthma. The duo improved lung function ...

The pharmacologic effects of beta 2-adrenoceptor agonist drugs, including salmeterol ... LABA monotherapy (without ICS) may increase risk of asthma-related events (death, hospitalizations ...

Continuing our series, Dr Andrew Whittamore debunks some common myths about asthma – and explains some less well-known facts ...

The multicenter study randomized 196 patients with poorly controlled asthma despite moderate to high doses of inhaled corticosteroid and long-acting β2 adrenergic agonist (ICS/LABA) treatment.

Novartis says that around a third of patients with asthma have symptoms that can’t be controlled using LABA/ICS dual therapy such as GSK’s older drug Seretide – which dominated the market ...